Analyst
Truist Securities
Equibles does not estimate personal net worth.
Rich Newitter is recorded as Analyst at Truist Securities. Rich Newitter has spoken on 2 earnings calls and 3 other investor events across 4 companies, most recently for iRhythm Holdings, Inc. on June 16, 2026. Those appearances were for Vericel Corp (VCEL), iRhythm Holdings, Inc. (IRTC), Integer Holdings Corp (ITGR) and GLAUKOS Corp (GKOS). The companies whose calls Rich Newitter spoke on are classified in the Healthcare sector.
“And our next fireside, we have iRhythm, and we have Dan Wilson. Dan, welcome. What's that?”
“Our next fireside chat is going to be with Integer, and we are very fortunate to have Integer's CEO and President Payman Kales and CFO and Executive Vice President Darren Smith.”
“Very lucky to have Glaucos Management, Alex Thurman, Chief Financial Officer, and Chris Lewis, Head of Investor Relations, joining us. Welcome, gentlemen, and thanks for attending this year.”
“I just wanted to to get a better understanding of where you're potentially seeing Macy Arthro actually, you know, potentially getting used where the traditional Macy was not, you know, just the cannibalization versus market expansion, you know, anything anecdotal that you can give us there.”
“So I was jumping around some calls, so I apologize, But it sounds like the effectively reiterating Macy, even though 2G wasn't quite at the guide, but just under, and it's really just maybe a slight call down from EpiCell for the full year, and you hope to exceed that, but just to be prudent.”
Truist Securities
Analyst
Transcript header (unverified)
VCEL
Biotechnology · Healthcare
GKOS
Medical Devices · Healthcare
